Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®

Exclusion Criteria

• •Patients participating in another study
• •Unfractionated heparin (UFH) use up to 30 days prior to surgical procedure
• •Renal failure with creatinine clearance \<30 ml / min
• •Known history of peripheral venous thrombosis and/or deep venous thrombosis in the 3 months prior to inclusion
• •Pregnant or breastfeeding women or women of childbearing age not using medically accepted contraceptive method
• •Anticoagulant use in the 3 months prior to inclusion
• •Patients with known haemostatic disorder
• •Patients not consenting to participate in the study, or not capable of understanding its objectives